Histopathological characterization of splenic lesions in splenectomized dogs

Authors

  • Filliphe Santos BARROS Dpto de Oncologia Clínica e Cirúrgica Veterinária, Universidade Brasil.
  • Eduardo Gomes DE PAULA Universidade Brasil
  • Felipe Augusto Ruiz SUEIRO Laboratório de Análises Clínicas VETPAT
  • Paulo César JARK Universidade Brasil

Keywords:

Histopathological characterization, splenectomy, hemangiossarcoma, splenic lesion, neoplasm

Abstract

The spleen plays vital roles in the immune and hematopoietic systems of dogs. Splenic abnormalities are common and frequently diagnosed, requiring precise evaluations to determine the appropriate course of treatment. In veterinary medicine, there is no consensus on differentiating these alterations; therefore, a commonly used practice is total splenectomy followed by histopathological evaluation. Histopathological evaluation of a large number of spleen lesions can draw veterinarians' attention to the percentage of reactive or benign splenic lesions in dogs, guiding them to find new differentiation patterns for these lesions before performing splenectomy. This study reviewed 1,164 cases of splenic lesions in dogs between 2008 and 2018. The data reveal that 55.9% of the lesions are non-neoplastic, while 34.7% are malignant neoplasms, with splenic hemangiosarcoma (HSA) being prominent. Benign neoplasms represented 9.4% of the samples. The average age of the animals ranges from 9.7 to 10.5 years, depending on the type of lesion. Mixed-breed dogs are most affected, representing 25.6% of the cases. These results underscore the importance of histopathological evaluation in differentiating between benign and malignant lesions. Additionally, they suggest that many splenectomies could have been avoided with a better understanding of the characteristics of splenic lesions. These findings have significant implications for surgical decision-making, highlighting the need for a more careful and individualized approach to the treatment of splenic
lesions in dogs.

References

AL-RUKIBAT, R.K.; BANI ISMAIL, Z.A. Unusual presentation of splenic myelolipoma in a

dog. The Canadian Veterinary Journal, v.47, n.11, p.1112-1114, 2006.

BANDINELLI, M.B.; PAVARINI, S.P.; OLIVEIRA, E.C; GOMES, D.C.; CRUZ, C.E.F.;

DRIEMEIER, D. Estudo retrospectivo de lesões em baços de cães esplenectomizados: 179 casos. Pesquisa Veterinária Brasileira, v.31, n.8, p.697-701, 2011.

CAMPOS, A.G. Esplenomegalias em cães: estudo retrospectivo e análise

imunohistoquímica do Fator de Crescimento Endotelial Vascular (VEGF), 2010.74p.

(Dissertação de Mestrado em Medicina Veterinária). Faculdade de Medicina Veterinária e Zootecnia, Universidade de São Paulo, São Paulo, 2010.

DAY, M.J.; LUCKE, V.M.; PEARSON, H. A review of pathological diagnoses made from 87

canine splenic biopsies. Journal of Small Animal Practice, v.36, n.10, p.426-433,1995.

DIONÍSIO, M.I.M. Prevalência da doença esplénica em cães e sobrevivência após

esplenectomia: estudo retrospectivo, 2016. 62p. (Dissertação de Mestrado em Medicina

Veterinária). Faculdade de Medicina Veterinária, Universidade de Lisboa, Lisboa, 2016.

EBERLE, N.; BABO, V.V.; NOLTE, I.; BAUMGÄRTNER, W.; BETZ, D. Splenic masses in

dogs. Part 1: Epidemiologic, clinical characteristics as well as histopathologic diagnosis in 249 cases (2000–2011). Tierärztliche Praxis Ausgabe K: Kleintiere / Heimtiere, v.40, n.4,p.250-260, 2012.

FIGUEIREDO, R.S.; MURAMOTO, C.; FONTES, T.N.; MENESES, I.D.S.; CARDOSO,

P.G.S.; VIEIRA FILHO, C.H.C.; ESTRELA-LIMA, A.; PEIXOTO T.C. Lesions in 224 spleens

of splenectomized dogs and evalution of alternative techniques for previous microscopic

diagnosis. Pesquisa Veterinária Brasileira, v.39, n.8, p.622-629, 2019.

FRY, M.M.; MCGAVIN, M.D. Bone Marrow, Blood Cells, and Lymphatic System. In:

MCGAVIN, M.D.; ZACHARY, J.F. Pathologic Basis of Veterinary Disease. 4. ed., St. Louis,

Missouri: Mosby Elsevier, 2007. p.809-821.

HAMMOND, T.N.; PESILLO-CROSBY, S.A. Prevalence of hemangiosarcoma in anemic

dogs with a splenic mass and hemoperitoneum requiring a transfusion: 71 cases (2003-2005).

Journal of the American Veterinary Medical Association, v.232, n.4, p.553-558, 2008

KAMIIE, J.; FUEKI, K.; AMAGAI, H.; ICHIKAWA, Y.; SHIROTA, K. Multicentric

myelolipoma in a dog. Journal of Veterinary Medical Science v.,71, n.3, p.371-373, 2009.

KISSEBERTH, W.C.; MCENTEE, M.C. Doenças do baço. In: BICHARD, S J.; SHERDING,

R.G. Manual Saunders Clínica de Pequenos Animais. 3. ed., São Paulo: Roca, 2008. p.277-287.

MARONEZI, M.C.; CARNEIRO, R.K.; DA CRUZ, I.C.K.; DE OLIVEIRA, A.P.L.; DE

NARDI, A.B.; PAVAN, L.; AGUILA-SILVA, P.D.E.L.; USCATEGUI, R.A.R.; FELICIANO,

M.A.R. Accuracy of B-mode ultrasound and ARFI elastography in predicting malignancy of canine splenic lesions. Scientific Reports, v.452, n.12, p.1-7, 2022.

PRESS, C.M.; LANDSVERK, T. Immune System. In: EURELL, J.A. & FRAPPIER, B.L.

Dellmann’s Textbook of Veterinary Histology. 6. ed., Ames, Iowa: Blackwell Publishing,

p.147-152.

PRYMAK, C.; MCKEE, L.J.; GOLDSCHMIDT, M.H.; GLICKMAN, L.T. Epidemiologic,

clinical, pathologic, and prognostic characteristics of splenic hemangiosarcoma and splenic

hematoma in dogs: 217 cases (1985). Journal of the American Veterinary Medical

Association, v.193, n.6, p.706-711, 1988.

RICHTER, M.C. Spleen. In: TOBIAS, K.M. & JOHNSTON, S.A. Veterinary Surgery Small

Animal. 1. ed., St. Louis, Missouri: Saunders Elsevier, 2012. p.1341-1352.

RODIGHERI, S.M.; DE CAMPOS, G.F.; ROMANI, M.S. Avaliação clínica, hematológica e

histopatológica de tumores esplênicos em cães. Archives of Veterinary Science, v.21, supl.02, p.54-58, 2016.

SILVA, E.O.; DI SANTIS, G.W.; HEADLEY, S.A.; BRACARENCE, A.P.F.R.L. Splenic

lesions observed in 71 splenectomized dogs: a retrospective study. Semina: Ciências Agrárias, Londrina, v.37, n.5, p.3181-3188, 2016.

SPANGLER, W.L.; CULBERTSON. Prevalence, Type, and Importance of Splenic Diseases in

Dogs: 1.480 Cases (1985–1989). Journal of the American Veterinary Medical Association,

v200, n.6, p.829–834, 1992.

SPANGLER, W.L.; CULBERTSON, M.R.; KASS, P.H. Primary mesenchymal

(nonangiomatous/nonlymphomatous) neoplasms occurring in the canine spleen: anatomic classification, immunohistochemistry, and mitotic activity correlated with patient survival. Veterinary Pathology. v.31, n.1, p.37-47, 1994.

VAIL, D.M.; YOUNG, K.M. Hematopoetic tumors. In: WITHROW, S.J.; VAIL, D.M. Small

Animal Clinical Oncology. 4. ed., St. Louis: Saunders Elsevier, 2007. p.699-722.

ZIMMER, M.A.; STAIR, E.L. Splenic myelolipomas in two dogs. Veterinary Pathology.

v.20, n.5, p.637-638, 1983.

Published

2024-12-30

How to Cite

BARROS, F. S.; PAULA, E. G. D.; SUEIRO, F. . A. R.; JARK, P. C. Histopathological characterization of splenic lesions in splenectomized dogs. Ciência Animal, [S. l.], v. 34, n. 4, p. 50–60, 2024. Disponível em: https://revistas.uece.br/index.php/cienciaanimal/article/view/14716. Acesso em: 4 jan. 2025.

Issue

Section

Artigos Originais